Serous carcinoma of the corpus uteri

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Apr 2026Study of EV for Recurrent Endometrial Carcinoma

William Bradley — PHASE2

TrialNOT YET RECRUITING
Jan 2026Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

National Cancer Institute (NCI) — PHASE3

TrialRECRUITING
Apr 2025Serous Endometrial Intraepithelial Carcinoma (SEIC): Prospective Registration Study

Erasmus Medical Center

TrialNOT YET RECRUITING
Jan 2022A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

DualityBio Inc. — PHASE1, PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Serous carcinoma of the corpus uteri.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Serous carcinoma of the corpus uteri.
Search all trials →
Search clinical trials for Serous carcinoma of the corpus uteri

Recent News & Research

No recent news articles indexed yet for Serous carcinoma of the corpus uteri.
Search PubMed for Serous carcinoma of the corpus uteri

Browse all Serous carcinoma of the corpus uteri news →

Specialist Network

Top 6 by expertise

View all Serous carcinoma of the corpus uteri specialists →

Quick Actions